Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors. [electronic resource]
- Journal of cancer research and clinical oncology Jul 2010
- 1065-71 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-009-0753-7 doi
Adult Aged Benzamides Disease Progression Drug Resistance, Neoplasm Female Follow-Up Studies Gastrointestinal Stromal Tumors--diagnosis Genotype Humans Imatinib Mesylate Male Middle Aged Mutation Piperazines--therapeutic use Proto-Oncogene Proteins c-kit--antagonists & inhibitors Pyrimidines--therapeutic use Receptors, Platelet-Derived Growth Factor--antagonists & inhibitors Signal Transduction--genetics